Evolving stroke and the ischemic penumbra

Neurology

Volumn 47, Issue 4, 1996, Pages 884-888

  Fisher, Marc ^a   Garcia, Julio H ^b  

^a Med Center of Central Massachusetts   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN OXYGEN CONSUMPTION; CEREBROVASCULAR DISEASE; DISEASE SEVERITY; HUMAN; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0029807883     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.4.884     Document Type: Review

References (45)

1. Britton M, Reden A. Progression of stroke after arrival at hospital. Stroke 1985;16:629-632.
2. Davalos A, Cendra E, Teruel J, Martinez M, Genis D. Deteriorating ischemic stroke: risk factors and prognosis. Neurology 1990;40:1865-1869.
3. Toni D, Fiorelli M, Gentile M, et al. Progressing neurological deficit secondary to acute ischemic stroke. Arch Neurol 1995; 52:670-675.
4. Jones HR, Millikan CH. Temporal profile (clinical course) of acute carotid system cerebral infarction. Stroke 1976;7:64-71.
5. Jones HR, Millikan CH, Sandok AS. Temporal profile (clinical course) of acute vertebrobasilar system cerebral infarction. Stroke 1980;11:173-177.
6. Lyden PD, Lau GT. A critical appraisal of stroke evaluation and scoring scales. Stroke 1991;22:1345-1352.
7. Millikan CH, Siekert RG. Studies in cerebral vascular disease. IV. The syndrome of intermittent insufficiency of the carotid arterial system. Proc Staff Mayo Clin 1955;30:186-191.
8. Fisher CM. Anticoagulant therapy in cerebral thrombosis and cerebral embolism: a national cooperative study, interim report. Neurology 1961;11:119-131.
9. Genton E, Barnett HJM, Fields WJ, Lent M, Hoak JC. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy. Stroke 1977; 8:150-175.
10. Asplund K. Any progress on progressing stroke? Cerebrovasc Dis 1992;2:317-319.
11. Fisher CM. Use of anticoagulants in cerebral thrombosis. Neurology 1958;8:311-332.
12. Carter AB. Anticoagulant treatment in progressive stroke. BMJ 1961;2:70-73.
13. Marsh EE, Adams HP, Biller J, et al. Use of antithrombotic drugs in the treatment of acute ischemic stroke: a survey of neurologists in practice in the United States. Neurology 1989; 39:1631-1634.
14. Fisher M, Takano K. The penumbra, therapeutic time window and acute ischemic stroke. In: Hachinski V, ed. Balliere's clinical neurology, cerebrovascular disease. London, Balliere Tindall, 1995:279-296.
15. Astrup J, Symon L, Siesjo BK. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 1981;12:723-725.
16. Symon L, Branston NM, Strong AJ, et al. The concepts of thresholds of ischemia in relation to brain structure and function. J Clin Pathol 1977;30(suppl 11):149-154.
17. Kinouchi H, Sharp FR, Koistinaho J, et al. Induction of heat shock HSP70 messenger RNA and HSP70-K DNA protein in neurons in the penumbra following cerebral ischemia. Brain Res 1993;619:334-338.
18. Hakin AM. The cerebral ischemic penumbra. Can J Neurol Sci 1987;14:557-559.
19. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994;362:557-565.
20. Ginsberg MD, Pulsinelli WA. The ischemic penumbra, injury thresholds and the therapeutic window for acute stroke. Ann Neurol 1994;36:553-554.
21. Baron JC. Pathophysiology of acute cerebral ischemia: PET studies in humans. J Cereb Blood Flow Metab 1991;1(suppl 1):22-31.
22. Heiss WD, Graf R, Wienhard K, et al. Dynamic penumbra demonstrated by sequential multi-tracer PET after middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab 1994;14:892-902.
23. Pappata S, Fiorelli M, Ronnel T, et al. PET study of changes in local brain hemodynamics and oxygen metabolism after unilateral middle cerebral artery occlusion in baboons. J Cereb Blood Flow Metab 1993;13:416-424.
24. Touzani A, Young AR, Declon JM, et al. Sequential studies of severely hypometabolic tissue volumes after permanent middle cerebral artery occlusion: a positron emission tomographic investigation in anesthetized baboons. Stroke 1995;26:2112-2119.
25. Marchal G, Serrati C, Rioux P, et al. PET imaging of cerebral perfusion and oxygen consumption in acute ischemia: relation to outcome. Lancet 1993;341:925-927.
26. Fisher M, Sotak CH, Minematsu K, Li L. Innovative magnetic resonance technologies for evaluating cerebrovascular disease. Ann Neurol 1992;32:115-122.
27. Hasegawa Y, Fisher M, Latour LL, et al. MRI diffusion mapping of reversible and irreversible ischemic injury in focal brain ischemia. Neurology 1994;44:1484-1490.
28. Warach S. New magnetic resonance imaging technologies for stroke diagnosis and treatment evaluation. In: Fisher M, ed. Stroke therapy. Boston: Butterworth-Heinemann, 1995:65-80.
29. Paczynski R, Hsu CY, Diringer MN. Pathophysiology of ischemic injury. In: Fisher M, ed. Stroke therapy. Boston: Butterworth-Heinemann, 1995:29-64.
30. Garcia JH, Liu KF, Yoshida Y, et al. Brain microvessels: factors altering their patency after occlusion of a middle cerebral artery. Am J Pathol 1994;195:721-740.
31. Takagi K, Ginsberg MD, Glabur M, et al. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbra region following middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1993;12:575-585.
32. Park CK, Nehls DG, Graham DT, et al. Focal cerebral ischemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischemia. J Cereb Blood Flow Metab 1988;8:757-762.
33. Nedergard M, Hansen AJ. Characterization of cortical depolarization evoked in focal cerebral ischemia. J Cereb Blood Flow Metab 1993;12:568-574.
34. Takano K, Latour L, Formato JE, et al. Spreading depression contributes to the evolution of experimental focal brain ischemia evaluated by diffusion mapping. Ann Neurol 1996; 39:308-318.
35. Garcia JH, Mitchem LH, Briggs L, et al. Transient focal ischemia in subhuman primates: neuronal injury as a function of local cerebral blood flow. J Neuropathol Exp Neurol 1983; 42:44-60.
36. del Zoppo GH, Copeland BR, Harker LA, et al. Experimental acute thrombotic stroke in baboons. Stroke 1986;17:1254-1265.
37. Garcia JH, Liu K-F, Fisher M, Tatlisumak T. Non-neuronal cells, their responses to focal brain ischemia [abstract]. Cerebrovasc Dis 1996;6:180.
38. Garcia JH, Yoshida Y, Chen H, et al. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol 1993;142:623-635.
39. Garcia JH, Liu K-F, Ho K-L. Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke 1995;26:636-643.
40. Garcia JH, Liu K-F, Yoshida Y. Brain microvessels: factors altering their patency following the occlusion of a middle cerebral artery. Am J Pathol 1994;145:728-740.
41. Garcia JH, Wagner S, Liu K-F, Hu X-J. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats: statistical validation. Stroke 1995;26:627-635.
42. Garcia JH, Liu K-F, Relton JK. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol 1995;147:1477-1486.
43. Pulsinelli W. The ischemic penumbra in stroke. Sci Amer Sci Med 1995;2:16-25.
44. Fieschi C, Argentino C, Lenzi G, et al. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 1989;91:311-321.
45. The National Institute of Neurological Disorders and Stroke rt-PA Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.